GHC Genetics CZ

What GHC Genetics CZ does

GHC Genetics CZ (GHC Genetics, s.r.o.) is a privately-held Czech genetic testing laboratory founded in 2007 and headquartered in Prague at V Holešovičkách 1156/29, Prague 8. The company operates its own accredited in-house laboratory (accredited for medical genetics and, since December 2023, medical microbiology) and offers a portfolio of more than 80 genetic tests spanning predictive genetics, hereditary cancers, reproductive genetics, cardiovascular risk (e.g., TromboGen®), pharmacogenetics (including DPYD for 5-fluorouracil dosing), prenatal diagnostics (NIPT — GenePlanet Plus/Twin), microbiome analysis, dental health (DentalScan®, DentinoScan, Oral Microbiome), infectious diseases/STD testing, and kinship/paternity testing. Its core technical platform is molecular genetic analysis using Next Generation Sequencing — most recently upgraded in February 2025 with an Illumina NextSeq 2000 sequencer featuring XLEAP-SBS chemistry and integrated DRAGEN secondary analysis — alongside digitalMLPA, MLPA, STR marker analysis, and microbiome sequencing.

The company runs a hybrid go-to-market model. Direct-to-consumer tests are sold through the ghcgenetics.cz e-commerce website, with home DNA sample collection kits shipped nationwide; test prices range from approximately 350 Kč to 9,800 Kč ($15-$415). A parallel physician-driven channel — anchored by a referral network of over 1,400 doctors at Czech teaching hospitals and major medical facilities — drives insurance-covered testing under contracts with all major Czech health insurance providers (VZP, OZP, and others), with physician consultations required to confirm clinical indication. GHC Genetics reports approximately 6,300 genetic consultations per year, operates a dedicated STD collection centre at Polyclinic Prosek (Prague 9) since April 2025, and collaborates with scientific partners including Masaryk University (Horizon Europe FH-EARLY project) and the CZECANCA cancer genetics consortium. It was ranked among the TOP 10 European genetic laboratories by HealthcareTech OUTLOOK in 2023 and operates within the GHC Healthcare Worldnet group. No external venture or private equity backing is disclosed; the company has been self-funded since inception.

Customer segments span health-conscious preventive-care consumers, individuals with family history of hereditary disease, pregnant women seeking NIPT, patients requiring STD screening, dental patients, and individuals seeking kinship verification; the company is part of the GHC Healthcare Worldnet group. Pricing is unit-based across 80+ tests with express 24-hour turnaround available for an additional 1,500 Kč fee, and occasional promotional discounts (e.g., OZP-insured 50% off TromboGen Plus in December 2024-January 2025). The company is GDPR-compliant, accepts multiple payment methods (Comgate, Visa, Mastercard, Apple Pay, Google Pay, Pluxee), and ships sample kits via Zásilkovna. Management includes CEO Viktor Furman and Head of Molecular Genetics and Microbiology Laboratory Renáta Michalovská.

Name

GHC Genetics CZ

Legal name

GHC Genetics, s.r.o.

Website

https://ghcgenetics.cz

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

GHC Genetics CZ is a Prague-based, privately-held accredited genetic testing laboratory offering 80+ DNA tests across hereditary cancers, reproductive genetics, pharmacogenomics, NIPT, microbiome, STD, and kinship, sold via DTC e-commerce, physician referrals, and contracts with all major Czech health insurers.

Ownership category

akta.pro rank

Product category

Genetic Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Genetic testing services
• Molecular diagnostics
• Clinical genetics laboratory
• Predictive genetic analysis
• DNA paternity testing

Headquarters

HQ city

Prague

HQ country

Czechia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Direct-to-Consumer Genetic Testing (Self-Paying Patients): Individual consumers purchase genetic tests directly through the GHC Genetics e-shop. Tests range from single targeted tests (e.g., Celiac disease, Lactose intolerance) to comprehensive panels (GenScan Complex). Prices range from approximately 1,100 Kč to over 5,900 Kč per test. Home sample collection kits are shipped to customers.
2. Insurance-Covered Genetic Testing (Indicated Patients): Patients who meet clinical indication criteria (assessed at genetic consultation) receive full insurance coverage for genetic testing including laboratory analysis and physician consultation. GHC Genetics has contracts with all Czech health insurance companies. The consultation referral must come from attending physician.
3. Kinship and Paternity Testing: DNA kinship testing including paternity, maternity, and ancestry tests. Performed anonymously for private purposes. Results delivered within 5 business days. Sold directly to consumers.
4. Infectious Disease / STD Testing: Microbiological testing for sexually transmitted diseases and other infectious diseases. Offered at dedicated sampling center at Polyclinic Prosek. Prices range from 350 Kč to 7,450 Kč depending on test complexity. Express results available within 24 hours for additional fee.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

GHC Genetics CZ operates an accredited clinical genetics laboratory in Prague providing molecular genetic testing and analysis across 80+ tests. Core offerings include comprehensive predictive genetic analysis (GenScan Complex), microbiome composition analysis, reproductive and prenatal genetics, hereditary cancer gene panels, cardiovascular and thrombosis risk assessment, dental genetic testing, pharmacogenetics, STD/infectious disease diagnostics, and kinship/paternity DNA testing. All tests are processed in-house using NGS technology, with physician consultations and personalized prevention recommendations integrated into the service delivery.

Product overview

GHC Genetics CZ operates as a comprehensive genetic testing laboratory offering a portfolio of 80+ tests. The core offering includes GenScan® Complex (comprehensive genetic analysis) and Mikrobiom (intestinal microbiome analysis), with specialized add-on modules covering reproductive genetics (ReproScreen), cardiovascular risks (TromboGen®), hereditary cancers (BRCA1,2 Screen, Oncopanel), metabolic disorders (lactose intolerance, celiac disease), dental care (DentalScan®, DentinoScan, Oral Microbiome), prenatal diagnostics (NIPT - GenePlanet Plus/Twin), pharmacogenetics, infectious/STD testing, and kinship testing (paternity/maternity DNA tests). The company performs all analyses in its own accredited laboratory in Prague, providing sample collection kits for home use and physician consultations.

Differentiator

Problem solved

Functional benefit

Brands

• GenScan®: Comprehensive genetic analysis test that provides answers on how to eliminate health issues, avoid inappropriately chosen treatments, or stay healthier longer
• GenScan Complex
• TromboGen®
• TromboGen Plus
• TromboGen Gravidity
• ReproScreen
• BRCA1,2 Screen
• DentalScan®
• DentinoScan
• Chromozoom
• Microbiom/Microbiome
• Orální mikrobiom (Oral Microbiome)
• Oncopanel
• GenePlanet Plus
• GenePlanet Twin

Products and services

• GenScan Complex
• Chromozoom
• Mikrobiom (Intestinal Microbiome Analysis)
• Orální mikrobiom (Oral Microbiome)
• DentalScan
• DentinoScan
• ReproScreen
• TromboGen
• BRCA1,2 Screen
• Oncopanel — Hereditary Cancer Gene Panel
• GenePlanet Plus and GenePlanet Twin (NIPT)
• STD Testing Panels (Basic, Standard, Complex, Premium)
• HPV DNA Testing (30 types)
• Paternity and Maternity DNA Tests
• Pharmacogenetic Testing
• Single-Gene Hereditary Disease Tests
• Metabolic Disorder Genetic Tests
• TromboGen Gravidity
• CLL Testing (Chronic Lymphocytic Leukemia)
• Genetic Consultation with Clinical Geneticist

Quantifiable outcome

• Non-invasive prenatal testing achieves >99% accuracy for Down, Patau, and Edwards syndromes.
• +7 more outcomes

Named customers3 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature7 records

Partnerships

15 partnerships are on record, tiered core and minor.

• PRENET (Prenatal Diagnostic Center)coreStrategic or Co-development PartnerPRENET is a sister company and specialist prenatal diagnostic center in Pardubice providing comprehensive prenatal services including NIPT testing (GenePlanet Plus and GenePlanet Twin) using GHC Genetics laboratory. PRENET offers 3D/4D ultrasound, first and second trimester screening, amniocentesis, CVS, and genetic counseling. GHC Genetics is part of the GHC Healthcare Worldnet group.
• Česká asociace pro vzácná onemocnění (Czech Association for Rare Diseases)minorStrategic or Co-development PartnerPatient organization representing individuals with rare diseases. GHC Genetics partners with this organization to support awareness and diagnosis of hereditary conditions.
• ASGENT (Organizace pacientů s Angelmanovým syndromem)minorStrategic or Co-development PartnerGHC Genetics has been a proud partner and supporter of Asgent for several years. Asgent focuses on developing a therapeutic procedure for Angelman syndrome, and GHC Genetics provides laboratory expertise and support for this research initiative.
• Pacientská organizace VERONICAminorGTM or Marketing PartnerPatient organization bringing together patients with endometrial, vulvar, ovarian, and cervical cancer and women with BRCA1 and BRCA2 genetic mutations. GHC Genetics established cooperation in February to support patient awareness and genetic testing advocacy.
• Česká společnost AIDS pomocminorGTM or Marketing PartnerCzech AIDS Society partnership for awareness of HIV and sexually transmitted infections. GHC Genetics provides STD testing services that align with the organization's public health mission.
• GYNORDplusminorStrategic or Co-development PartnerGynecology-focused healthcare partner. Collaboration supports gynecological genetics and reproductive health testing services.
• Grácie - oáza pro ženy (Lysá nad Labem shelter)minorGTM or Marketing PartnerWomen's health organization. GHC Genetics conducted charity fundraiser and donation activities with this partner, providing wooden decorations worth CZK 18,000 to their children's ward.
• Illumina, Inc.coreTechnology or IntegrationGHC Genetics laboratory acquired Illumina NextSeq 2000 sequencer — an advanced next-generation DNA sequencing platform with throughput up to 540 Gb and XLEAP-SBS chemistry. This is a key technology partnership for the company's molecular genetic analysis capabilities.
• University Hospital Motol (Department of Molecular Genetics)minorStrategic or Co-development PartnerGHC Genetics participates in Interlaboratory Quality Control of Molecular Genetic Diagnosis of Cystic Fibrosis, organized by University Hospital Motol's Department of Molecular Genetics. GHC Genetics received maximum points for genotyping and clinical interpretation.
• Masaryk University Faculty of Medicine / Centre for Cardiovascular and Transplant Surgery BrnocoreStrategic or Co-development PartnerCollaboration in the Horizon Europe FH-EARLY pan-European project investigating familial hypercholesterolemia. GHC Genetics contributes laboratory and clinical data and coordinates gene discovery and genetic risk score development. Company has an extensive database of genetically characterized FH patients.
• Czech Centre for Phenogenomics (CCP)minorStrategic or Co-development PartnerGHC Genetics supports the Czech Centre for Phenogenomics which conducts cutting-edge genetic research. CCP studies rare diseases (approximately 7,000 known rare diseases affecting 500,000 people in the Czech Republic) and develops gene therapy approaches.
• VZP ČR (General Health Insurance Company of the Czech Republic)coreChannel Partner/ Reseller/ DistributorVZP is the largest Czech health insurer. GHC Genetics has a contract with VZP for coverage of genetic tests including Kaftrio medication for cystic fibrosis. VZP also covers genetic testing for indicated patients. GHC Genetics participated in joint preventive campaigns with VZP.
• OZP (Health Insurance Company for Bank, Insurance and Civil Engineering Employees)minorChannel Partner/ Reseller/ DistributorOZP partnered with GHC Genetics for a limited-time promotional campaign (December 2024–January 2025), offering insureds a 50% discount on TromboGen Plus examination (1,200 Kč instead of standard price).
• CZECANCA (Czech National Cancer Genetics Alliance)coreStrategic or Co-development PartnerGHC Genetics is a long-term active partner of the CZECANCA project, contributing laboratory and clinical data to scientific studies such as the comprehensive evaluation of germline FANCG variants in predisposition to breast and ovarian cancer.
• Home for Trees (Domov pro stromy)minorOthersEnvironmental organization focused on forest restoration. GHC Genetics employees participated in tree-planting activities organized by Home for Trees, which has planted 55,000 new trees in the Czech Republic since 2019. GHC Genetics supports environmental CSR initiatives.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Natera: US-listed genetic testing company specializing in cell-free DNA testing (NIPT, oncology, organ transplant monitoring) with growing international presence. Comparable on NIPT technology and hereditary cancer panels, though at significantly larger scale and with global commercial reach.
• SYNLAB: One of Europe's largest medical-diagnostics networks operating clinical laboratories across multiple countries, including Central Europe. Overlaps with GHC Genetics on clinical chemistry, microbiology and molecular diagnostics, but at vastly greater scale and as part of a much broader routine-testing portfolio.
• Unilabs: Major European clinical diagnostics provider offering routine and specialty testing (including molecular diagnostics and infectious disease) across multiple European countries. Overlaps with GHC Genetics on STD/infectious disease and molecular testing, but as part of a much broader routine-testing portfolio.

Emerging players

• Dante Labs: Europe-based whole-genome sequencing company targeting consumers and clinicians with low-cost WGS and rare-disease analysis. Comparable to GHC Genetics on consumer-facing genetic testing and European positioning, but focused specifically on WGS rather than the broad test-panel approach.

Direct peers

• Invitae: US-based genetic information company offering a broad NGS-based menu (hereditary cancer, reproductive health, rare disease). Direct overlap with GHC Genetics on panel breadth and physician-referred genetic testing, though Invitae serves a global customer base.
• Centogene: Germany-based rare-disease and genetic diagnostics laboratory with a European-wide physician network and multi-omics testing portfolio (NGS, NIPT, biomarker testing). Comparable mid-sized European genetic lab with a similar model of physician referrals plus direct testing.
• Myriad Genetics: US-based molecular diagnostics pioneer with deep hereditary cancer testing heritage (BRCA1/2, multi-gene cancer panels), pharmacogenetics and prenatal testing. Directly comparable to GHC Genetics' Oncopanel, BRCA1/2 Screen and pharmacogenetics offerings, though Myriad operates at much larger US/global scale.
• Eurofins Genomics: Large European genomic services provider offering Sanger, NGS, pharmacogenomic, microbiome and cell-free DNA testing from multiple European labs. Directly comparable to GHC Genetics in molecular diagnostics service breadth, European footprint, and clinical/research customer base.
• 23andMe: US DTC genetic testing leader offering health-risk, ancestry and pharmacogenetic reports to consumers globally. Comparable to GHC Genetics' DTC motion (Chromozoom, GenScan), online ordering, and home sample collection — though with a much larger consumer brand.
• GenePlanet: Slovenia-based preventive genetics company offering NIPT, reproductive and health-risk genetic tests directly to consumers and through clinicians across Europe. Notably, GHC Genetics uses the 'GenePlanet Plus' and 'GenePlanet Twin' brand names for its NIPT products — indicating a direct partnership/overlap with GenePlanet, which is also a direct competitor in CEE markets for preventive genetic testing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ghcgenetics
• LinkedInlinkedin.com/company/ghc-genetics-cz
• Instagraminstagram.com/ghcgeneticscz

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GHC Genetics CZ